Gritstone Oncology Inc buy Piper Sandler
Start price
28.09.23
/
50%
€1.42
Target price
28.09.24
€6.63
Performance (%)
-47.96%
Price
24.05.24
€0.74
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler for Gritstone Oncology Inc is performing very badly with a performance of -47.96%. This prediction currently runs until 28.09.24. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Gritstone Oncology Inc | 7.558% | 7.558% |
iShares Core DAX® | -0.205% | 2.949% |
iShares Nasdaq 100 | 1.613% | 5.877% |
iShares Nikkei 225® | -0.740% | -1.256% |
iShares S&P 500 | 0.267% | 3.240% |
Comments by Piper_Sandler for this prediction
In the thread Gritstone Oncology Inc diskutieren
Gritstone bio, Inc. (NASDAQ: GRTS) had its price target raised by analysts at Piper Sandler from $6.00 to $7.00. They now have an "overweight" rating on the stock.
Ratings data for GRTS provided by MarketBeat